Evidence map›Paper›PMID 25790387›Full record

ArticleAmerican journal of public health2015

Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program.

Michelle Housey, Peter DeGuire, Sarah Lyon-Callo, Lu Wang, Wendy Marder, W Joseph McCune, Charles G Helmick, Caroline Gordon, J Patricia Dhar, James Leisen and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Global epidemiology of systemic lupus erythematosus.Nature reviews. Rheumatology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Epidemiology of systemic lupus erythematosus: an update.Current opinion in rheumatology · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Michelle HouseyMichelle Housey, Peter DeGuire, and Sarah Lyon-Callo are with the Michigan Department of Community Health, Lansing. Lu Wang is with the Department of Biostatistics, University of Michigan, Ann Arbor. Wendy Marder, W. Joseph McCune, and Emily C. Somers are with the Department of Internal Medicine, University of Michigan, Ann Arbor. Charles G. Helmick is with the Centers for Disease Control and Prevention, Atlanta, GA. Caroline Gordon is with the University of Birmingham, Birmingham, UK. J. Patricia Dhar is with the Central Michigan University College of Medicine, Mount Pleasant. James Leisen is with the Henry Ford Health System, Division of Rheumatology, Detroit, MI.
Peter DeGuire
Sarah Lyon-Callo
Lu Wang
Wendy Marder
W Joseph McCune
Charles G Helmick
Caroline Gordon
J Patricia Dhar
James Leisen
Emily C Somers
University of Michigan · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Michigan BIRCWH Career Development ProgramK12HD001438 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHNSON, TIMOTHY RB · 2000 to 2014
$6.7M
PUBLIC HLTH APPROACHES TO ARTHRITIS IN MICHIGANU58DP001441 · DP · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI LYLES, JUDITH S · 2008 to 2011
$5.0M
Immune dysfunction associated with early life heavy metal exposureK01ES019909 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SOMERS, EMILY CATHERINE · 2011 to 2015
$670k
Intramural CDC HHS CC999999NCCDPHP CDC HHS U58 DP001441NCCDPHP CDC HHS U58/DP001441NCHM CDC HHS 5U38HM000414-5NCHM CDC HHS U38 HM000414NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1-RR-024986NICHD NIH HHS K12 HD001438NICHD NIH HHS K12HD001438NIEHS NIH HHS K01 ES019909PHS HHS U58/CCU522826
6 · The paper itself

Abstract

objectivesWe assessed the burden of systemic lupus erythematosus (SLE) among Arab and Chaldean Americans residing in southeast Michigan.

methodsFor those meeting SLE criteria from the Michigan Lupus Epidemiology and Surveillance Registry, we determined Arab or Chaldean ethnicity by links with demographic data from birth certificates and with a database of Arab and Chaldean names. We compared prevalence and incidence of SLE for Arab and Chaldean Americans with estimates for non-Arab and non-Chaldean American Whites and Blacks.

resultsWe classified 54 individuals with SLE as Arab and Chaldean Americans. The age-adjusted incidence and prevalence estimates for Arab and Chaldean Americans were 7.6 and 62.6 per 100 000, respectively. Arab and Chaldean Americans had a 2.1-fold excess SLE incidence compared with non-Arab and non-Chaldean American Whites. Arab and Chaldean American women had both significantly higher incidence rates (5.0-fold increase) and prevalence estimates (7.4-fold increase) than did Arab and Chaldean American men.

conclusionsRecognizing that Arab and Chaldean Americans experience different disease burdens from Whites is a first step toward earlier diagnosis and designing targeted interventions. Better methods of assigning ethnicity would improve research in this population.

Indexed as

AdultArabsFemaleHumansIncidenceLupus Erythematosus, SystemicMaleMichiganMiddle AgedPrevalencePublic Health SurveillanceSocioeconomic Factors

Identifiers

PMID25790387
PMCPMC4386493
OpenAlexW2026331229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.